165 related articles for article (PubMed ID: 31206615)
21. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
Schönauer R; Sierks D; Boerrigter M; Jawaid T; Caroff L; Audrezet MP; Friedrich A; Shaw M; Degenhardt J; Forberger M; de Fallois J; Bläker H; Bergmann C; Gödiker J; Schindler P; Schlevogt B; Müller RU; Berg T; Patterson I; Griffiths WJ; Sayer JA; ; Popp B; Torres VE; Hogan MC; Somlo S; Watnick TJ; Nevens F; Besse W; Cornec-Le Gall E; Harris PC; Drenth JPH; Halbritter J
Gastroenterology; 2024 May; 166(5):902-914. PubMed ID: 38101549
[TBL] [Abstract][Full Text] [Related]
22. The medical management of abnormal uterine bleeding in reproductive-aged women.
Bradley LD; Gueye NA
Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
[TBL] [Abstract][Full Text] [Related]
23. Noncontraceptive health benefits of oral steroidal contraceptives.
Mishell DR
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
[TBL] [Abstract][Full Text] [Related]
24. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women.
Snow KK; Cote J; Yang W; Davis NJ; Seddon JM
Am J Ophthalmol; 2002 Dec; 134(6):842-8. PubMed ID: 12470752
[TBL] [Abstract][Full Text] [Related]
25. Portal hypertension due to extensive hepatic cysts in autosomal dominant polycystic kidney disease.
Misra A; Loyalka P; Alva F
South Med J; 1999 Jun; 92(6):626-7. PubMed ID: 10372860
[TBL] [Abstract][Full Text] [Related]
26. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
McTiernan AM; Weiss NS; Daling JR
Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
[TBL] [Abstract][Full Text] [Related]
27. Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment.
Uddin W; Ramage JK; Portmann B; Wilson P; Benjamin I; Tan KC; Williams R
Gut; 1995 Jan; 36(1):142-5. PubMed ID: 7890219
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease.
Takei R; Ubara Y; Hoshino J; Higa Y; Suwabe T; Sogawa Y; Nomura K; Nakanishi S; Sawa N; Katori H; Takemoto F; Hara S; Takaichi K
Am J Kidney Dis; 2007 Jun; 49(6):744-52. PubMed ID: 17533017
[TBL] [Abstract][Full Text] [Related]
29. Treatment of polycystic liver disease. Update on the management.
Aussilhou B; Dokmak S; Dondero F; Joly D; Durand F; Soubrane O; Belghiti J
J Visc Surg; 2018 Dec; 155(6):471-481. PubMed ID: 30145049
[TBL] [Abstract][Full Text] [Related]
30. Strong impact of estrogen environment on Doppler variables used for differentiation between benign and malignant breast lesions.
Germer U; Tetzlaff A; Geipel A; Diedrich K; Gembruch U
Ultrasound Obstet Gynecol; 2002 Apr; 19(4):380-5. PubMed ID: 11952968
[TBL] [Abstract][Full Text] [Related]
31. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
Shulman LP
Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
[TBL] [Abstract][Full Text] [Related]
32. Intravascular embolization therapy in patients with enlarged polycystic liver.
Hoshino J; Ubara Y; Suwabe T; Sumida K; Hayami N; Mise K; Hiramatsu R; Hasegawa E; Yamanouchi M; Sawa N; Takei R; Takaichi K
Am J Kidney Dis; 2014 Jun; 63(6):937-44. PubMed ID: 24602778
[TBL] [Abstract][Full Text] [Related]
33. Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.
Neijenhuis MK; Gevers TJ; Hogan MC; Kamath PS; Wijnands TF; van den Ouweland RC; Edwards ME; Sloan JA; Kievit W; Drenth JP
Hepatology; 2016 Jul; 64(1):151-60. PubMed ID: 26970415
[TBL] [Abstract][Full Text] [Related]
34. Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use.
O'Brien SN; Anandjiwala J; Price TM
Obstet Gynecol; 1997 Aug; 90(2):244-8. PubMed ID: 9241302
[TBL] [Abstract][Full Text] [Related]
35. The effects of progesterone and progestins on endometrial proliferation.
Moyer DL; Felix JC
Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
[TBL] [Abstract][Full Text] [Related]
36. Adult polycystic liver and kidney diseases are separate entities.
Karhunen PJ; Tenhu M
Clin Genet; 1986 Jul; 30(1):29-37. PubMed ID: 3757294
[TBL] [Abstract][Full Text] [Related]
37. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Polycystic Liver Disease.
Savige J; Mallett A; Tunnicliffe DJ; Rangan GK
Semin Nephrol; 2015 Nov; 35(6):618-622.e5. PubMed ID: 26718168
[No Abstract] [Full Text] [Related]
38. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
39. Estrogens in polycystic liver disease: A target for future therapies?
Aapkes SE; Bernts LHP; Barten TRM; van den Berg M; Gansevoort RT; Drenth JPH
Liver Int; 2021 Sep; 41(9):2009-2019. PubMed ID: 34153174
[TBL] [Abstract][Full Text] [Related]
40. The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression.
Neijenhuis MK; Kievit W; Perrone RD; Sloan JA; Erwin P; Murad MH; Gevers TJG; Hogan MC; Drenth JPH
BMC Nephrol; 2017 May; 18(1):169. PubMed ID: 28545401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
